Second cancers following non-Hodgkin's lymphoma
- National Cancer Institute, Bethesda, MD (USA)
The risk of second malignancies following non-Hodgkin's lymphoma (NHL) was estimated in 29,153 patients diagnosed with NHL between 1973 and 1987 in one of nine areas participating in the National Cancer Institute's Surveillance, Epidemiology, and End Results Program. Compared with the general population, NHL patients were at a significantly increased risk of developing second cancers (observed/expected (O/E) = 1.18; O = 1231). The O/E ratio increased significantly with time to reach 1.77 in 10-year survivors. Significant excesses were noted for acute nonlymphocytic leukemia (O/E = 2.88), cancers of the bladder (O/E = 1.30), kidney (O/E = 1.47), and lung (O/E = 1.57), malignant melanoma (O/E = 2.44), and Hodgkin's disease (O/E = 4.16). Chemotherapy appeared related to subsequent acute nonlymphocytic leukemia (ANLL) and bladder cancer. Radiation therapy was associated with ANLL and possibly cancers of the lung, bladder, and bone. Malignant melanoma was not clearly related to initial NHL treatment.
- OSTI ID:
- 5952558
- Journal Information:
- Cancer (Philadelphia); (USA), Vol. 67:7; ISSN 0008-543X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nonrandom chromosomal abnormalities in acute nonlymphocytic leukemia in patients treated for Hodgkin disease and non-Hodgkin lymphomas
Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma
Related Subjects
HODGKINS DISEASE
RADIOINDUCTION
LEUKEMIA
LYMPHOMAS
RADIOTHERAPY
NEOPLASMS
SIDE EFFECTS
BIOLOGICAL RADIATION EFFECTS
PATIENTS
RISK ASSESSMENT
BIOLOGICAL EFFECTS
DISEASES
HEMIC DISEASES
IMMUNE SYSTEM DISEASES
MEDICINE
NUCLEAR MEDICINE
RADIATION EFFECTS
RADIOLOGY
THERAPY
560151* - Radiation Effects on Animals- Man